Skip to content
Lower risk Medical device recall · FDA · Published October 21, 2025

Medtronic CareLink Clinic Software Error May Cause Incorrect Glucose Readings

Medtronic recalls CareLink Clinic REF: MMT-7350 due to software error causing incorrect glucose data displays, which could lead to unsafe blood sugar levels. Affected users should check their device software version.

🇺🇸 FDA recall #Z-0594-2026Medical deviceMedtronic ›
Take action

Contact the company

Recalling firmMedtronic MiniMed, Inc.18000 Devonshire St · Northridge, CA 91325-1219
✎ GovInfoNow plain-language explainer

Medtronic is recalling CareLink Clinic devices with software version 4.2B because a software error may show incorrect glucose readings. This could lead to unsafe blood sugar levels if users make decisions based on the wrong data. Read more at govinfonow.com/recall/51038-medtronic-carelink-clinic-software-error-may-cause-incorrect-glucose-readings.

Source Summary by GovInfoNow · govinfonow.com/recall/51038-medtronic-carelink-clinic-software-error-may-cause-incorrect-glucose-readings · Updated August 18, 2026 · FDA enforcement record: FDA #Z-0594-2026

Cite this page

“Medtronic CareLink Clinic Software Error May Cause Incorrect Glucose Readings.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/51038-medtronic-carelink-clinic-software-error-may-cause-incorrect-glucose-readings. Based on FDA recall #Z-0594-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0594-2026%22&limit=1).

The FDA announced on Oct. 21, 2025, that Medtronic MiniMed, Inc. is recalling CareLink Clinic (REF: MMT-7350) due to a software error displaying incorrect data on the 24-hour Sensor Glucose Overview Graph. This hazard may lead users to make therapy decisions based on false information, potentially causing hypoglycemia or hyperglycemia.

How to tell if you have it

  • Brand: Medtronic
  • Product: CareLink Clinic
  • REF: MMT-7350
  • UDI-DI: 0763000B00008748K
  • Software Versions: 4.2B
  • Units affected: 12,126

The hazard

A software error causes incorrect data to be displayed on the 24-hour Sensor Glucose Overview Graph. Any potential therapy decisions made based on this incorrect data may lead to hypoglycemia or hyperglycemia.

Context

GovInfoNow's records show Medtronic MiniMed, Inc. has 13 other recalls on record since Nov. 15, 2023. Recent recalls include a June 16, 2026, issue with the MiniMed Go App that may cause missed insulin doses and a May 27, 2026, recall of the MiniMed 780G Insulin Pump for software errors causing insulin stoppage. Other recent recalls of similar products include Nova Biomedical StatStrip Glucose Meter Software Issue Causes Patient Data Errors (July 29, 2026) and Dexcom G7 CGM App: Hypoglycemia Risk Due to Glucose Data Delays (April 14, 2026).

How to tell if you have this one

Check if your CareLink Clinic device shows software version 4.2B. The device was sold between September 4th, 2025, and October 3rd, 2025, in the US, and between September 11th, 2025, and October 4th, 2025, outside the US.

  • Brand
    Medtronic
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Software Version

    Look for the software version on your CareLink Clinic device. If it shows 4.2B, you are affected.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 48 states.

Alaska: named in the noticeAKMaine: nationwideMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide Distribution: US (nationwide) including states of: TX, NC, MN, CA, VA, ID, WA, GA, MI, MA, OH, IL, IA, CT, FL, PA, NY, TN, AZ, LA, AL, NJ, CO, SC, MS, OR, MT, MD, KS, AK, NH, NE, WY, ND, IN, MO, WI, KY, UT, NV, SD, WV, NM, HI,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 43 days after the firm started it.

1. Firm started the recall: Oct 21, 202512. FDA classified it Class II: Nov 25, 202523. Published in FDA’s Enforcement Report: Dec 3, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Medtronic recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0594-2026 (October 21, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0594-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA